Mike Dullen

Scientist at Ultragenyx

Speaker

A scientist at Ultragenyx Pharmaceutical Inc., developing gene therapies for rare and ultra-rare diseases. I have over 10 years of experience in the biopharmaceutical industry, with a passion for helping people and developing novel techniques. My core competencies include end-to-end upstream and downstream process development for recombinant adeno-associated viral (rAAV) vectors, which are used to deliver therapeutic genes to target cells. I have a strong understanding of viral vector production, including media formulation, transfection, bioreactor design and optimization, filtration, chromatography, and inactivation. I have also been involved in the development of new technologies and methods to improve vector yields, quality, and scalability, as well as the preparation of CMC documents for regulatory filings. My goal is to contribute to the advancement of gene therapy and bring innovative therapies to patients.